NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumours
Collaboration agreement strengthens 61Cu-supply chain capabilities for clinical development in North America BASEL, Switzerland and BOCA RATON, Fla., May 15, 2023 /PRNewswire/ — NUCLIDIUM and PharmaLogic Holdings today announced that they have entered into a strategic collaboration agreement for the production and clinical supply of 61Cu in the United States to accelerate the development of … Read more